Selected research
Market Outlook & Growth Opportunities
Global Mung Bean Peptide Market Outlook and Growth Opportunities 2026
Market perspective
The global Mung Bean Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Mung Bean Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mung Bean Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mung Bean Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Mung Bean Peptide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Mung Bean Peptide market include WaterSolubleProtein, Shanxi Y-Herb Biotechnology Co., Ltd, Wuhan Healthdream Biological Technology Co. Ltd, Nutraonly (Xi'an) Nutritions Inc, Zhongshi Duqing (Shandong) Biotech Co., Ltd, Wuhan Tallyho Biological Product Co., Ltd and Xi'an Le Sen Bio-technology Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Mung Bean Peptide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mung Bean Peptide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mung Bean Peptide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mung Bean Peptide market size, projected growth trends, production technologies, key applications, and end-use industries.
Mung Bean Peptide Segment by Company
WaterSolubleProtein
Shanxi Y-Herb Biotechnology Co., Ltd
Wuhan Healthdream Biological Technology Co. Ltd
Nutraonly (Xi'an) Nutritions Inc
Zhongshi Duqing (Shandong) Biotech Co., Ltd
Wuhan Tallyho Biological Product Co., Ltd
Xi'an Le Sen Bio-technology Co., Ltd
Mung Bean Peptide Segment by Type
Dry Powder
Liquid
Mung Bean Peptide Segment by Application
Medical & Healthcare
Food & Beverage
Cosmetics
Animal Feed
Mung Bean Peptide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Mung Bean Peptide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Mung Bean Peptide market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Mung Bean Peptide significant trends, drivers, influence factors in global and regions.
6. To analyze Mung Bean Peptide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mung Bean Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mung Bean Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mung Bean Peptide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mung Bean Peptide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mung Bean Peptide industry.
Chapter 3: Detailed analysis of Mung Bean Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Mung Bean Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Mung Bean Peptide in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Dry Powder
- Liquid
Applications
- Medical & Healthcare
- Food & Beverage
- Cosmetics
- Animal Feed
Companies covered
- WaterSolubleProtein
- Shanxi Y-Herb Biotechnology Co., Ltd
- Wuhan Healthdream Biological Technology Co. Ltd
- Nutraonly (Xi'an) Nutritions Inc
- Zhongshi Duqing (Shandong) Biotech Co., Ltd
- Wuhan Tallyho Biological Product Co., Ltd
- Xi'an Le Sen Bio-technology Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Mung Bean Peptide Sales Value (2021-2032)
- 1.2.2 Global Mung Bean Peptide Sales Volume (2021-2032)
- 1.2.3 Global Mung Bean Peptide Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Mung Bean Peptide Market Dynamics
- 2.1 Mung Bean Peptide Industry Trends
- 2.2 Mung Bean Peptide Industry Drivers
- 2.3 Mung Bean Peptide Industry Opportunities and Challenges
- 2.4 Mung Bean Peptide Industry Restraints
3 Mung Bean Peptide Market by Company
- 3.1 Global Mung Bean Peptide Company Revenue Ranking in 2025
- 3.2 Global Mung Bean Peptide Revenue by Company (2021-2026)
- 3.3 Global Mung Bean Peptide Sales Volume by Company (2021-2026)
- 3.4 Global Mung Bean Peptide Average Price by Company (2021-2026)
- 3.5 Global Mung Bean Peptide Company Ranking (2024-2026)
- 3.6 Global Mung Bean Peptide Company Manufacturing Base and Headquarters
- 3.7 Global Mung Bean Peptide Company Product Type and Application
- 3.8 Global Mung Bean Peptide Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Mung Bean Peptide Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Mung Bean Peptide Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Mung Bean Peptide Market by Type
- 4.1 Mung Bean Peptide Type Introduction
- 4.1.1 Dry Powder
- 4.1.2 Liquid
- 4.2 Global Mung Bean Peptide Sales Volume by Type
- 4.2.1 Global Mung Bean Peptide Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mung Bean Peptide Sales Volume by Type (2021-2032)
- 4.2.3 Global Mung Bean Peptide Sales Volume Share by Type (2021-2032)
- 4.3 Global Mung Bean Peptide Sales Value by Type
- 4.3.1 Global Mung Bean Peptide Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Mung Bean Peptide Sales Value by Type (2021-2032)
- 4.3.3 Global Mung Bean Peptide Sales Value Share by Type (2021-2032)
5 Mung Bean Peptide Market by Application
- 5.1 Mung Bean Peptide Application Introduction
- 5.1.1 Medical & Healthcare
- 5.1.2 Food & Beverage
- 5.1.3 Cosmetics
- 5.1.4 Animal Feed
- 5.2 Global Mung Bean Peptide Sales Volume by Application
- 5.2.1 Global Mung Bean Peptide Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mung Bean Peptide Sales Volume by Application (2021-2032)
- 5.2.3 Global Mung Bean Peptide Sales Volume Share by Application (2021-2032)
- 5.3 Global Mung Bean Peptide Sales Value by Application
- 5.3.1 Global Mung Bean Peptide Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Mung Bean Peptide Sales Value by Application (2021-2032)
- 5.3.3 Global Mung Bean Peptide Sales Value Share by Application (2021-2032)
6 Mung Bean Peptide Regional Sales and Value Analysis
- 6.1 Global Mung Bean Peptide Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mung Bean Peptide Sales by Region (2021-2032)
- 6.2.1 Global Mung Bean Peptide Sales by Region: 2021-2026
- 6.2.2 Global Mung Bean Peptide Sales by Region (2027-2032)
- 6.3 Global Mung Bean Peptide Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Mung Bean Peptide Sales Value by Region (2021-2032)
- 6.4.1 Global Mung Bean Peptide Sales Value by Region: 2021-2026
- 6.4.2 Global Mung Bean Peptide Sales Value by Region (2027-2032)
- 6.5 Global Mung Bean Peptide Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Mung Bean Peptide Sales Value (2021-2032)
- 6.6.2 North America Mung Bean Peptide Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Mung Bean Peptide Sales Value (2021-2032)
- 6.7.2 Europe Mung Bean Peptide Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Mung Bean Peptide Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Mung Bean Peptide Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Mung Bean Peptide Sales Value (2021-2032)
- 6.9.2 South America Mung Bean Peptide Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Mung Bean Peptide Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Mung Bean Peptide Sales Value Share by Country, 2025 VS 2032
7 Mung Bean Peptide Country-level Sales and Value Analysis
- 7.1 Global Mung Bean Peptide Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Mung Bean Peptide Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Mung Bean Peptide Sales by Country (2021-2032)
- 7.3.1 Global Mung Bean Peptide Sales by Country (2021-2026)
- 7.3.2 Global Mung Bean Peptide Sales by Country (2027-2032)
- 7.4 Global Mung Bean Peptide Sales Value by Country (2021-2032)
- 7.4.1 Global Mung Bean Peptide Sales Value by Country (2021-2026)
- 7.4.2 Global Mung Bean Peptide Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.9.2 France Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.16.2 China Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.19.2 India Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Mung Bean Peptide Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Mung Bean Peptide Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Mung Bean Peptide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 WaterSolubleProtein
- 8.1.1 WaterSolubleProtein Company Information
- 8.1.2 WaterSolubleProtein Business Overview
- 8.1.3 WaterSolubleProtein Mung Bean Peptide Sales, Value and Gross Margin (2021-2026)
- 8.1.4 WaterSolubleProtein Mung Bean Peptide Product Portfolio
- 8.1.5 WaterSolubleProtein Recent Developments
- 8.2 Shanxi Y-Herb Biotechnology Co., Ltd
- 8.2.1 Shanxi Y-Herb Biotechnology Co., Ltd Company Information
- 8.2.2 Shanxi Y-Herb Biotechnology Co., Ltd Business Overview
- 8.2.3 Shanxi Y-Herb Biotechnology Co., Ltd Mung Bean Peptide Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Shanxi Y-Herb Biotechnology Co., Ltd Mung Bean Peptide Product Portfolio
- 8.2.5 Shanxi Y-Herb Biotechnology Co., Ltd Recent Developments
- 8.3 Wuhan Healthdream Biological Technology Co. Ltd
- 8.3.1 Wuhan Healthdream Biological Technology Co. Ltd Company Information
- 8.3.2 Wuhan Healthdream Biological Technology Co. Ltd Business Overview
- 8.3.3 Wuhan Healthdream Biological Technology Co. Ltd Mung Bean Peptide Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Wuhan Healthdream Biological Technology Co. Ltd Mung Bean Peptide Product Portfolio
- 8.3.5 Wuhan Healthdream Biological Technology Co. Ltd Recent Developments
- 8.4 Nutraonly (Xi'an) Nutritions Inc
- 8.4.1 Nutraonly (Xi'an) Nutritions Inc Company Information
- 8.4.2 Nutraonly (Xi'an) Nutritions Inc Business Overview
- 8.4.3 Nutraonly (Xi'an) Nutritions Inc Mung Bean Peptide Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Nutraonly (Xi'an) Nutritions Inc Mung Bean Peptide Product Portfolio
- 8.4.5 Nutraonly (Xi'an) Nutritions Inc Recent Developments
- 8.5 Zhongshi Duqing (Shandong) Biotech Co., Ltd
- 8.5.1 Zhongshi Duqing (Shandong) Biotech Co., Ltd Company Information
- 8.5.2 Zhongshi Duqing (Shandong) Biotech Co., Ltd Business Overview
- 8.5.3 Zhongshi Duqing (Shandong) Biotech Co., Ltd Mung Bean Peptide Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Zhongshi Duqing (Shandong) Biotech Co., Ltd Mung Bean Peptide Product Portfolio
- 8.5.5 Zhongshi Duqing (Shandong) Biotech Co., Ltd Recent Developments
- 8.6 Wuhan Tallyho Biological Product Co., Ltd
- 8.6.1 Wuhan Tallyho Biological Product Co., Ltd Company Information
- 8.6.2 Wuhan Tallyho Biological Product Co., Ltd Business Overview
- 8.6.3 Wuhan Tallyho Biological Product Co., Ltd Mung Bean Peptide Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Wuhan Tallyho Biological Product Co., Ltd Mung Bean Peptide Product Portfolio
- 8.6.5 Wuhan Tallyho Biological Product Co., Ltd Recent Developments
- 8.7 Xi'an Le Sen Bio-technology Co., Ltd
- 8.7.1 Xi'an Le Sen Bio-technology Co., Ltd Company Information
- 8.7.2 Xi'an Le Sen Bio-technology Co., Ltd Business Overview
- 8.7.3 Xi'an Le Sen Bio-technology Co., Ltd Mung Bean Peptide Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Xi'an Le Sen Bio-technology Co., Ltd Mung Bean Peptide Product Portfolio
- 8.7.5 Xi'an Le Sen Bio-technology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Mung Bean Peptide Value Chain Analysis
- 9.1.1 Mung Bean Peptide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Mung Bean Peptide Sales Mode & Process
- 9.2 Mung Bean Peptide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Mung Bean Peptide Distributors
- 9.2.3 Mung Bean Peptide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst